Related references
Note: Only part of the references are listed.Survival Prognosis, Tumor Immune Landscape, and Immune Responses of ADAMTS14 in Clear Cell Renal Cell Carcinoma and Its Potential Mechanisms
Yinhao Chen et al.
FRONTIERS IN IMMUNOLOGY (2022)
A basement membrane discovery pipeline uncovers network complexity, regulators, and human disease associations
Ranjay Jayadev et al.
SCIENCE ADVANCES (2022)
Basement membrane remodeling guides cell migration and cell morphogenesis during development
David R. Sherwood
CURRENT OPINION IN CELL BIOLOGY (2021)
Basement membrane stiffness determines metastases formation
Raphael Reuten et al.
NATURE MATERIALS (2021)
Development of a four-gene prognostic model for clear cell renal cell carcinoma based on transcriptome analysis
Yuenan Liu et al.
GENOMICS (2021)
Thrombospondin-4 promotes bladder cancer cell migration and invasion via MMP2 production
Kuang-Yu Chou et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Identification of an Altered Matrix Signature in Kidney Aging and Disease
Michael J. Randles et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
clusterProfiler 4.0: A universal enrichment tool for interpreting omics data
Tianzhi Wu et al.
INNOVATION (2021)
A DNA methylation signature to improve survival prediction of gastric cancer
Yaojun Peng et al.
CLINICAL EPIGENETICS (2020)
Bioinformatics Identified 17 Immune Genes as Prognostic Biomarkers for Breast Cancer: Application Study Based on Artificial Intelligence Algorithms
Zhiqiao Zhang et al.
FRONTIERS IN ONCOLOGY (2020)
THBS4 promotes HCC progression by regulating ITGB1 via FAK/PI3K/AKT pathway
Dan Guo et al.
FASEB JOURNAL (2020)
A signature of immune-related gene pairs predicts oncologic outcomes and response to immunotherapy in lung adenocarcinoma
Feng Xu et al.
GENOMICS (2020)
TILRR (FREM1 isoform 2) is a prognostic biomarker correlated with immune infiltration in breast cancer
Xiao-Yi Xu et al.
AGING-US (2020)
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
Aurelien Marabelle et al.
LANCET ONCOLOGY (2020)
Elevated expression of FREM1 in breast cancer indicates favorable prognosis and high-level immune infiltration status
Han-ning Li et al.
CANCER MEDICINE (2020)
MT4-MMP in tumor-associated macrophages is linked to hepatocellular carcinoma aggressiveness and recurrence
Feng Qi et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel
Zhijie Wang et al.
JAMA ONCOLOGY (2019)
α-Integrins dictate distinct modes of type IV collagen recruitment to basement membranes
Ranjay Jayadev et al.
JOURNAL OF CELL BIOLOGY (2019)
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
T. A. Chan et al.
ANNALS OF ONCOLOGY (2019)
β6-integrin serves as a novel serum tumor marker for colorectal carcinoma
Susan Bengs et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
MT4-MMP: The GPI-Anchored Membrane-Type Matrix Metalloprotease with Multiple Functions in Diseases
Cassandre Yip et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Construction and comprehensive analysis of dysregulated long non-coding RNA-associated competing endogenous RNA network in clear cell renal cell carcinoma
Jiawu Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
The competing endogenous circular RNA ADAMTS14 suppressed hepatocellular carcinoma progression through regulating microRNA-572/regulator of calcineurin 1
Changlong Song et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Chondroitin Sulfate Proteoglycan 4 and its Potential As an Antibody immunotherapy Target across Different Tumor Types
Kristina M. Ilieva et al.
FRONTIERS IN IMMUNOLOGY (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
Basement membranes and autoimmune diseases
Mary H. Foster
MATRIX BIOLOGY (2017)
Integrin and dystroglycan compensate each other to mediate laminin-dependent basement membrane assembly and epiblast polarization
Shaohua Li et al.
MATRIX BIOLOGY (2017)
Renal cell carcinoma
James J. Hsieh et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Treatment of renal cell carcinoma: Current status and future directions
Pedro C. Barata et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Immune Checkpoint Therapy in Renal Cell Carcinoma
Chung-Han Lee et al.
CANCER JOURNAL (2016)
Understanding Pathologic Variants of Renal Cell Carcinoma: Distilling Therapeutic Opportunities from Biologic Complexity
Brian Shuch et al.
EUROPEAN UROLOGY (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Minor Type IV Collagen α5 Chain Promotes Cancer Progression through Discoidin Domain Receptor-1
Qian Xiao et al.
PLOS GENETICS (2015)
Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver
Alexandra Naba et al.
BMC CANCER (2014)
T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both In Vitro and In Vivo
Claudia Geldres et al.
CLINICAL CANCER RESEARCH (2014)
pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels
Paul Geeleher et al.
PLOS ONE (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Gabriela Bindea et al.
IMMUNITY (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Functional Characterization of an scFv-Fc Antibody that Immunotherapeutically Targets the Common Cancer Cell Surface Proteoglycan CSPG4
Xinhui Wang et al.
CANCER RESEARCH (2011)
Basement Membranes: Cell Scaffoldings and Signaling Platforms
Peter D. Yurchenco
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Regularization Paths for Generalized Linear Models via Coordinate Descent
Jerome Friedman et al.
JOURNAL OF STATISTICAL SOFTWARE (2010)
CSPG4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast Cancer
Xinhui Wang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Histological Subtype is an Independent Predictor of Outcome for Patients With Renal Cell Carcinoma
Bradley C. Leibovich et al.
JOURNAL OF UROLOGY (2010)
MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer
Anjum Sohail et al.
CANCER AND METASTASIS REVIEWS (2008)
Integrin alphavbeta6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver
Guang-Yun Yang et al.
CANCER SCIENCE (2008)
Thrombospondins in cancer
S. Kazerounian et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
The Fras1/Frem family of extracellular matrix proteins: Structure, function, and association with Fraser syndrome and the mouse bleb phenotype
Petros Petrou et al.
CONNECTIVE TISSUE RESEARCH (2008)
Type IV collagens regulate BMP signalling in Drosophila
Xiaomeng Wang et al.
NATURE (2008)
Functions of the conserved thrombospondin carboxy-terminal cassette in cell-extracellular matrix interactions and signaling
JC Adams
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Thrombospondin-4 and its variants - Expression and differential effects on endothelial cells
OI Stenina et al.
CIRCULATION (2003)
Microvascular basement membranes in diabetes mellitus
EC Tsilibary
JOURNAL OF PATHOLOGY (2003)
Alport's syndrome, Goodpasture's syndrome, and type IV collagen
BG Hudson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
